Journal-based CME Course: Total Neoadjuvant Therapy for Pancreatic Cancer – What Is Totality?

Activity ID

13123

Expires

April 24, 2027

Format Type

Journal-based

CME Credit

Fee

CME Provider: JAMA Surgery

Description of CME Course

This article discusses the meaning of the word total in relation to total neoadjuvant therapy for pancreatic cancer.

Disclaimers

1. This activity is accredited by the American Medical Association.
2. This activity is free to AMA members.

ABMS Member Board Approvals by Type

ABMS Lifelong Learning CME Activity

Allergy and Immunology

Anesthesiology

Colon and Rectal Surgery

Family Medicine

Medical Genetics and Genomics

Nuclear Medicine

Ophthalmology

Orthopaedic Surgery

Pathology

Physical Medicine and Rehabilitation

Plastic Surgery

Preventive Medicine

Psychiatry and Neurology

Radiology

Thoracic Surgery

Urology

More Information

Commercial Support?

NOTE: If a Member Board has not deemed this activity for MOC approval as an accredited CME activity, this activity may count toward an ABMS Member Board’s general CME requirement. Please refer directly to your Member Board’s MOC Part II Lifelong Learning and Self-Assessment Program Requirements.

General Information on CME Activity

Educational Objectives

To identify the key insights or developments described in this article

Keywords

Gastroenterology, Gastroenterology and Hepatology, Gastrointestinal Cancer, Oncology, Pancreatic Cancer

Competencies

Medical Knowledge

CME Credit Type

AMA PRA Category 1 Credit

DOI

10.1001/jamasurg.2024.0419